Fig. 4.

Partial response per type of systemic therapy as a function of time from when mitotane level was first observed above 14 mg/L. “As a function of time from when mitotane level was first observed above 14 mg/L” corresponds to the time when therapeutic plasma level was first observed above 14 mg/L in each patient, and not the initiation of mitotane as a monotherapy or with polychemotherapy. Data not available for a patient that received polychemotherapy + mitotane